A meibomian gland carcinoma in a 56-year-old white woman was treated elsewhere with what appeared to be an insufficient dose of radiotherapy followed by a recurrence one year after treatment. Radiotherapy was again given, resulting in apparent complete regression of the tumor. Thus far, after a followup period of 21 months, there has been no evidence of recurrence. External photographs and photomicrographs of the original and recurrent tumor are presented.
Ide CH, Ridings GR, Yamashita T, Buesseler JA. Radiotherapy of a Recurrent Adenocarcinoma of the Meibomian Gland. Arch Ophthalmol. 1968;79(5):540–544. doi:10.1001/archopht.1968.03850040542008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: